Latest polycystic kidney disease Stories
OMAHA, Neb., April 2 /PRNewswire-FirstCall/ -- Transgenomic, Inc. (OTC Bulletin Board: TBIO).
Thirteen Abstracts Will Be Featured at Annual Kidney Care Meeting EL SEGUNDO, Calif., March 25 /PRNewswire/ -- DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney failure and disease (CKD), in conjunction with DaVita Clinical Research(R), today announced that company representatives will present thirteen abstracts at the National Kidney Foundation's 2009 Spring Clinical Meetings scheduled for March 25-29, 2009 in Nashville, TN.
Canadian scientists suggest a protein extracted from yellow peas may help kidney patients. The study found laboratory rats with a severe form of kidney disease fed small daily doses of this protein had blood pressure drop 20 percent below that of the diseased rats fed only normal diets.
Researchers in Canada are reporting that proteins found in a common garden pea show promise as a natural food additive or new dietary supplement for fighting high blood pressure and chronic kidney disease (CKD).
Award amount increases despite troubling economy KANSAS CITY, Mo., March 11 /PRNewswire-USNewswire/ -- The PKD Foundation, the world's leader in PKD research, is once again teaming up with the International Society of Nephrology to honor three world renowned nephrologists with the 2009 Lillian Jean Kaplan International Prize for Advancement in the Understanding of Polycystic Kidney Disease.
LOS ANGELES, Oct. 29 /PRNewswire/ -- Inspired by his own life-saving kidney transplant, fashion critic and Entertainment Tonight correspondent Steven "Cojo" Cojocaru is taking steps to help the 12.5 million people worldwide affected by Polycystic Kidney Disease (PKD).
Jean Roark had her prayers answered four years ago when her husband, Dean, had a successful kidney transplant that rid him of a painful disease. Now they are hoping to aid others who are battling polycystic kidney disease by serving as local coordinators of the fourth annual Tucson Walk for PKD.
US-based drug discovery and development company Plexxikon has started a Phase I human clinical trial for PLX5568, a novel kinase inhibitor targeted for the treatment of at least two major indications with unmet medical needs pain as well as polycystic kidney disease.
Plexxikon Inc. today announced that it has initiated a Phase 1 human clinical trial for PLX5568, a novel kinase inhibitor targeted for the treatment of at least two major indications with unmet medical needs: pain as well as polycystic kidney disease (PKD).
Hair stylists are to hold an event to raise funds for the hospital unit which cared for a popular colleague.
- A trick or prank.